Financial Ratios | Themis Medicare Ltd. | R Wadiwala Securities Pvt Ltd

THEMIS MEDICARE LTD.

NSE : THEMISMEDBSE : 530199ISIN CODE : INE083B01024Industry : Pharmaceuticals & DrugsHouse : Private
BSE212.655.25 (+2.53 %)
PREV CLOSE (Rs.) 207.40
OPEN PRICE (Rs.) 212.00
BID PRICE (QTY) 211.25 (1)
OFFER PRICE (QTY) 212.00 (2)
VOLUME 2248
TODAY'S LOW / HIGH (Rs.)210.80 214.00
52 WK LOW / HIGH (Rs.)131.34 266
NSE212.455.1 (+2.46 %)
PREV CLOSE( Rs. ) 207.35
OPEN PRICE (Rs.) 210.95
BID PRICE (QTY) 212.25 (5)
OFFER PRICE (QTY) 212.55 (2)
VOLUME 15911
TODAY'S LOW / HIGH(Rs.) 209.00 214.45
52 WK LOW / HIGH (Rs.)132.6 263.85

Financial Ratios

Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)61.8379.2238.8626.97-11.70
   CEPS(Rs)7.328.953.782.63-0.55
   DPS(Rs)5.005.004.301.750.00
   Book NAV/Share(Rs)368.78312.22237.41198.67171.54
   Tax Rate(%)21.5323.4917.6711.6512.36
Margin Ratios
   Core EBITDA Margin(%)19.0424.2421.4617.691.24
   EBIT Margin(%)23.1726.3619.3215.30-1.66
   Pre Tax Margin(%)20.4724.1413.818.91-8.09
   PAT Margin (%)16.0618.4711.377.88-7.09
   Cash Profit Margin (%)19.0220.8715.0811.98-2.74
Performance Ratios
   ROA(%)11.7817.937.324.86-4.29
   ROE(%)18.1628.8413.099.34-8.00
   ROCE(%)20.5931.0715.2111.81-1.25
   Asset Turnover(x)0.730.970.640.620.60
   Sales/Fixed Asset(x)1.712.161.441.381.28
   Working Capital/Sales(x)2.833.774.047.8557.83
Efficiency Ratios
   Fixed Capital/Sales(x)0.580.460.690.730.78
   Receivable days126.4982.40142.49158.78140.57
   Inventory Days66.8455.1889.4897.99102.51
   Payable days130.5887.30163.89227.30203.52
Valuation Parameters
   PER(x)18.8711.787.218.900.00
   PCE(x)15.9310.427.419.13-54.03
   Price/Book(x)3.162.991.181.211.73
   Yield(%)0.430.541.530.730.00
   EV/Net Sales(x)3.242.311.381.561.91
   EV/Core EBITDA(x)14.528.915.998.0470.87
   EV/EBIT(x)13.978.757.1410.20-115.15
   EV/CE(x)2.192.060.860.911.14
   M Cap / Sales3.032.181.121.091.48
Growth Ratio
   Net Sales Growth(%)-10.2171.0714.439.71-12.29
   Core EBITDA Growth(%)-22.7392.3735.77690.93-82.35
   EBIT Growth(%)-21.11133.4344.471113.46-114.77
   PAT Growth(%)-21.93177.8765.20221.86-250.87
   EPS Growth(%)-21.95103.8744.06330.53-195.13
Financial Stability Ratios
   Total Debt/Equity(x)0.270.270.390.540.52
   Current Ratio(x)1.841.851.451.171.02
   Quick Ratio(x)1.381.350.990.840.67
   Interest Cover(x)8.5811.863.512.40-0.26
   Total Debt/Mcap(x)0.090.090.330.450.30